Arclio is a clinical-evidence platform for biopharma [2]. The company provides regulatory, clinical, and biostatistics teams with FDA-defensible answers from trial data in 30 seconds, rather than three days [2]. Arclio's approach differs from other tools by proving the correctness and integrity of data through deterministic, re-runnable computations on a tamper-evident evidence chain [2]. The platform operates entirely within client infrastructure, ensuring that no data moves externally [2]. Arclio produces publication-grade charts and an FDA readiness score [2]. The company is listed in the Apollo NYC AI directory under the devtools category [1] and operates in the technology, information and internet industry [3].
Something wrong or missing? Send a correction. Fixed within 24 hours.